Process, tube and device for the preparation of wound healant composition
The present invention is related to the field of tissue regeneration. It concerns more particularly new processes, tubes and devices for thrombin, platelet concentrate and wound healant preparations, alone or in combination with cell extracts, cell compositions and uses thereof.
1. A medical system for the preparation of a cell composition of platelet rich plasma and hyaluronic acid, comprising:
a tube comprising:
an anticoagulant; and
a hyaluronic acid,
wherein the tube is adapted to receive whole blood,
wherein the tube is adapted to be centrifuged for a duration in order to separate platelet rich plasma from the whole blood introduced into the tube, and to prepare the cell composition including the platelet rich plasma and the hyaluronic acid in the tube,
wherein prior to introduction of the whole blood into the tube and centrifugation, the anticoagulant is above the hyaluronic acid, and
wherein, when the tube is at least partially filled with the whole blood and centrifuged, blood components in the whole blood are separated into at least: (i) a supernatant comprising the cell composition of platelet rich plasma and hyaluronic acid; and (ii) red blood cells.
2. The system of claim 1 , wherein a percentage of red blood cells in the platelet rich plasma is reduced by more than 99% compared with the whole blood.
3. The system of claim 1 , wherein the tube is selected from:
a glass tube having a sodium citrate solution at approximately 0.1 M; or
a polyethylene terephthalate tube.
4. A medical system for the preparation of a cell composition of platelet rich plasma and hyaluronic acid, the system comprising:
a tube comprising:
an anticoagulant; and
a hyaluronic acid,
wherein the tube is adapted to receive whole blood,
wherein the tube is adapted to be centrifuged for a duration in order to separate platelet rich plasma from the whole blood, and to prepare the cell composition including the platelet rich plasma and the hyaluronic acid in the tube,
wherein prior to receiving whole blood and centrifugation, the anticoagulant and the hyaluronic acid are at least partially filled in the tube, and the hyaluronic acid is layered at the bottom of the tube and the anticoagulant is layered above the hyaluronic acid in the tube, and during centrifugation the hyaluronic acid migrates above the platelet rich plasma in the tube.
5. The system of claim 4 , wherein the anticoagulant comprises a sodium citrate solution at approximately 0.1 M.
6. The system of claim 4 , wherein the anticoagulant is selected from any hirudin, benzylsulfonyl-D-Arg-Pro-4-amidinobenzylamide (BAPA), heparin, sodium citrate, citrate, acid citrate dextrose (ACD), citrate-theophylline-adenosine-dipyridamole (CTAD), potassium-ethylenediaminetetraacetic acid (EDTA), or a combination thereof.
7. A method for the preparation of a cell composition of platelet rich plasma and hyaluronic acid, the method comprising:
collecting whole blood in a tube comprising a hyaluronic acid and an anticoagulant;
centrifuging the tube until migration of red blood cells under a platelet rich plasma and until migration of hyaluronic acid above the platelet rich plasma occurs;
mixing the hyaluronic acid and the platelet rich plasma by inverting the tube;
collecting the supernatant containing hyaluronic acid and the platelet rich plasma; and mixing the hyaluronic acid and the platelet rich plasma to obtain a cell composition of platelet rich plasma and hyaluronic acid,
wherein, prior to introduction of the whole blood into the tube, the anticoagulant and the hyaluronic acid are at least partially filled in the tube,
wherein the hyaluronic acid is beneath the anticoagulant in the tube prior to centrifugation, and during centrifugation the hyaluronic acid migrates above the platelet rich plasma in the tube.